Dynamic Healthcare M&A Database

Acquiring Party	Inverness Medical Innovations, Inc. (AMEX: IMA) (AMEX:IMA), a provider of rapid diagnostic products for women’s health and chronic disease self-management.
Transferring Party	Matritech, Inc. (AMEX:MZT), a leading developer of protein-based diagnostic and point-of-care products for the early detection and testing for bladder and other cancer.
Sector	Diagnostics
Date	August 28, 2007
Analysis Inverness expects opportunities to develop between Matritech and its existing point-of-care organization as well as with those of other recently acquired companies. Deal value -- $36m plus $2m earnout. Matritech's TTM revenue is $13.2m on negative EBITDA.
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 3Q07